AIAISci
中文
clinical trialBiotech

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma (NCT03334708)

updatedDate Venue ClinicalTrials.gov

Source-permitted summary

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma | Conditions: Pancreatic Cancer, Pancreatic Diseases, Pancreatitis

SourceClinicalTrials.gov

Verified by AISci

Public source attached

Source status for this paper in the current AISci reviewed snapshot.

Primary source
ClinicalTrials.gov
Correction status
none
Evidence coverage
1 sources / 1 publishers
Last metadata check
Jul 19, 2026
CLINICALTRIALS.GOV: NCT03334708
Open primary source

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma | Conditions: Pancreatic Cancer, Pancreatic Diseases, Pancreatitis
Field context
Diagnostics and Biomarkers
People and labs
Not stated in the reviewed source.
Why it matters
Clinical trial registry updates are translation signals, not commercialization claims by themselves.
Limits to check
ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.

Publication facts

Type
clinical trialSourceClinicalTrials.gov
Date
Jul 10, 2026SourceClinicalTrials.gov
Venue
ClinicalTrials.govSourceClinicalTrials.gov

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Topics

Diagnostics and Biomarkers

Relationship evidence

Timeline

  2. clinical trialA Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
    SourceClinicalTrials.gov